BTK is a member of the Tec kinase family and is a key player in B-cell activation and proliferation BTK inhibition has become a crucial strategy to disrupt the unchecked signaling that drives B-cell proliferation and contributes to various B-cell malignancies, including CLL. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.